TrialInfection and immunity2004

Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.

Elizabeth H Nardin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.